FIELD: medicine.
SUBSTANCE: group of invention refers to medicine, and aims at apoptosis induction in Jurkat cancer cells. What is declared is using donor carbon monoxide CORM-2 for apoptosis induction in Jurkat cancer cells. The method involves Jurkat cancer cell culture in a complete nutrient medium. Thereafter, CORM-2 is added in the final concentration of 50 mcM and exposed for 24 h in the 5% CO2 environment at temperature 37°C.
EFFECT: group of inventions enables the effective apoptosis induction and may be used for treating oncological diseases.
1 dwg, 3 tbl, 1 ex, 2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT OF APOPTOSIS-INDUCTIVE ACTIVITY | 2017 |
|
RU2654711C1 |
| MONONECLEAR DINITROSYL FERRIC COMPLEXES, METHOD FOR PREPARING MONONECLEAR DINITROSYL FERRIC COMPLEXES, NITROGEN MONOXIDE DONOR, USING MONONECLEAR DINITROSYL FERRIC COMPLEXES AS ANTI-TUMOUR DRUG | 2011 |
|
RU2494104C2 |
| APOPTOSIN AND ANTIOXIDANT COMPOSITION | 2017 |
|
RU2682644C2 |
| PEPTIDE COMPOUNDS FOR INDUCTION OF APOPTOSIS IN TUMOR CELL | 2021 |
|
RU2785794C2 |
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| METHOD OF PREVENTING INACTIVATION OF CELL DEATH CAUSED BY CYTOCHROME C | 2023 |
|
RU2811126C1 |
| APPLICATION OF PEPTIDE COMPOUND FOR APOPTOSIS INDUCTION IN A TUMOR CELL | 2022 |
|
RU2796104C1 |
| BIOLOGICAL MATERIALS AND APPLICATION THEREOF | 2006 |
|
RU2432363C9 |
| METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
| PREDICTION OF RESPONSE TO ALVICIDIB BY ANALYSIS OF MITOCHONDRION PROFILE | 2016 |
|
RU2717829C2 |
